Fresenius Medical Care AG & Co. KGaA FMS
22.69
0.34
1.52%
as of 25 Sep
- Market cap
- $11.9B
- P/E
- 11.8×
Follow FMS
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 6.77% | 6.58% | 6.66% | 4.95% |
+8 more TTM periods Free account |
|
| 3.01% | 3.04% | 3.10% | 2.24% | ||
ROIC |
5.78% | 5.45% | 5.84% | 4.69% | |
Return on Tangible Assets |
22.99% | 18.98% | 19.04% | 12.93% | |
Average Days of Receivables |
64.86 | 70.66 | 59.04 | 64.33 | |
Free Cash Flow per Share |
3.82 | 3.71 | 3.46 | 3.47 | |
Free Cash Flow |
2,052.84 | 2,041.59 | 2,016.52 | 2,029.51 | |
Capital Expenditures |
(1,179.97) | (1,085.71) | (1,016.76) | (806.22) | |
Piotroski F-Score |
6.00 | 6.00 | 6.00 | 6.00 | |
| Other line items | |||||
Cash ROIC |
12.33% | 11.44% | 11.34% | 10.74% | |
Accounts Receivable Turnover |
5.89 | 5.52 | 6.10 | 5.84 | |
Accounts Payable Turnover |
17.68 | 16.76 | 16.43 | 16.95 | |
Inventory Turnover |
6.71 | 6.81 | 7.09 | 6.86 | |
Average Days of Payables |
22.66 | 22.86 | 20.89 | 21.67 | |
Days of Inventory on Hand |
59.23 | 59.13 | 53.52 | 54.67 | |
Tax Rate |
(0.21) | (0.21) | (0.21) | (0.23) | |
Research and Development Expense of Revenue |
0.80% | 0.79% | 0.80% | 0.86% | |
Selling, General and Administrative Expense of Revenue |
15.32% | 15.66% | 15.45% | 15.71% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
2.98 | 2.88 | 2.74 | 3.52 | |
Depreciation/Fixed assets |
0.43 | 0.44 | 0.43 | 0.47 | |
Capex/Depreciation |
(0.66) | (0.60) | (0.60) | (0.45) | |
Revenue per Share |
42.23 | 40.80 | 38.13 | 37.18 | |
Operating CF per Share |
6.02 | 5.68 | 5.21 | 4.85 | |
Capex per Share |
(2.20) | (1.97) | (1.75) | (1.38) | |
Capex to Sales |
0.05 | 0.05 | 0.05 | 0.04 | |
Net Profit Margin |
4.78% | 4.83% | 4.98% | 3.71% |
Columns are period end dates